Golimumab maintains response in UC
Posted on: 01/01/2014 - 05:01
Subcutaneous golimumab induces and maintains clinical response in ulcerative colitis, according to two studies in the January issue of Gastroenterology. <link...
Field of Interest: Gastroentero...
Type: News Item
